Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7])

Y Kobayashi, N Ohshiro, R Sakai… - Journal of pharmacy …, 2005 - Wiley Online Library
Human organic anion transporter 2 (hOat2 [SLC22A7]) is highly expressed in the human liver.
Although localization, gene expression, substrate specificity and transport mechanisms of …

[PDF][PDF] The Drosophila trio plays an essential role in patterning of axons by regulating their directional extension

T Awasaki, M Saito, M Sone, E Suzuki, R Sakai, K Ito… - Neuron, 2000 - cell.com
We identified the Drosophila trio gene, which encodes a Dbl family protein carrying two Dbl
homology (DH) domains, each of which potentially activates Rho family GTPases. Trio was …

Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese …

…, M Tanaka, T Nanki, R Koike, R Sakai… - The Journal of …, 2011 - jrheum.org
Objective. To compare tumor necrosis factor-α (TNF-α) inhibitors to nonbiological disease-modifying
antirheumatic drugs (DMARD) for the risk of serious infection in Japanese patients …

Prevalence of patients with rheumatoid arthritis and age‐stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance …

A Nakajima, R Sakai, E Inoue… - International Journal of …, 2020 - Wiley Online Library
… Dr Nakajima and Dr Sakai contributed equally to 35% of this work in planning, data analysis,
interpretation of results, and writing this manuscript. Dr Harigai contributed to 20% of this …

Time‐dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis

R Sakai, Y Komano, M Tanaka, T Nanki… - Arthritis care & …, 2012 - Wiley Online Library
Objective To investigate associations between continuous treatments with tumor necrosis
factor (TNF) antagonists and risk for developing serious infections (SIs) over 3 years in …

[HTML][HTML] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from …

R Sakai, SK Cho, T Nanki, K Watanabe… - Arthritis research & …, 2015 - Springer
Introduction The objective of this study was to directly compare the safety of tocilizumab (TCZ)
and TNF inhibitors (TNFIs) in rheumatoid arthritis (RA) patients in clinical practice. …

Risk for malignancy in rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs compared to the general population: a nationwide …

…, K Watanabe-Imai, Y Komano, R Sakai… - Modern …, 2016 - academic.oup.com
Objectives: To investigate and compare the risk for malignancy in rheumatoid arthritis (RA)
patients treated with biologics in Japan to the general population. Methods: Data for 14,440 …

[HTML][HTML] Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results …

…, W Yokoyama, F Hirano, H Yamazaki, R Sakai… - Arthritis Research & …, 2017 - Springer
Background Sulfamethoxazole-trimethoprim (SMX/TMP) is a standard drug for the
prophylaxis of Pneumocystis pneumonia (PJP) in immunosuppressed patients with systemic …

Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk …

M Tanaka, R Sakai, R Koike, Y Komano… - Modern …, 2012 - Taylor & Francis
Objectives The association of anti-tumor necrosis factor therapy with opportunistic infections
in rheumatoid arthritis (RA) patients has been reported. The goal of this study was to clarify …

Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: results from a Japanese multi-institutional retrospective study

S Honda, R Sakai, E Inoue, M Majima… - Modern …, 2022 - academic.oup.com
Objectives To investigate the risk factors and clinical characteristics of lymphoproliferative
disorder (LPD) in Japanese patients with rheumatoid arthritis (RA). Methods We enrolled …